BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasmal S, Balasubrahmanyam D, Kanna Reddy HR, Balaji G, Srinivas G, Cheera S, Abbineni C, Sasmal PK, Khanna I, Sebastian V, Jadhav VP, Singh MP, Talwar R, Suresh J, Shashikumar D, Harinder Reddy K, Sihorkar V, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2. Bioorganic & Medicinal Chemistry Letters 2012;22:3163-7. [DOI: 10.1016/j.bmcl.2012.03.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chang TS, Lu CK, Hsieh YY, Wei KL, Chen WM, Tung SY, Wu CS, Chan MWY, Chiang MK. 2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. Int J Mol Sci 2020;21:E5901. [PMID: 32824603 DOI: 10.3390/ijms21165901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kumar A, Pasam VR, Thakur RK, Singh M, Singh K, Shukla M, Yadav A, Dogra S, Sona C, Umrao D, Jaiswal S, Ahmad H, Rashid M, Singh SK, Wahajuddin M, Dwivedi AK, Siddiqi MI, Lal J, Tripathi RP, Yadav PN. Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity. J Med Chem 2019;62:4638-55. [PMID: 30998358 DOI: 10.1021/acs.jmedchem.9b00241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cormier M, Ahmad M, Maddaluno J, De Paolis M. Forging C–C Bonds with Hindered Nucleophiles and Carbonyl Electrophiles: Reactivity and Selectivity of Allylic Tin Reagents/ n -BuLi. Organometallics 2017;36:4920-7. [DOI: 10.1021/acs.organomet.7b00765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Al-Shamary DS, Al-Alshaikh MA, Kheder NA, Mabkhot YN, Badshah SL. Molecular docking and biological evaluation of some thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and anticonvulsant agents. Chem Cent J 2017;11:48. [PMID: 29086826 DOI: 10.1186/s13065-017-0272-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
5 Igawa H, Takahashi M, Kakegawa K, Kina A, Ikoma M, Aida J, Yasuma T, Kawata Y, Ashina S, Yamamoto S, Kundu M, Khamrai U, Hirabayashi H, Nakayama M, Nagisa Y, Kasai S, Maekawa T. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives. J Med Chem 2016;59:1116-39. [PMID: 26736071 DOI: 10.1021/acs.jmedchem.5b01704] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
6 Dorn SC, Olsen AK, Kelemen RE, Shrestha R, Weix DJ. Nickel-catalyzed reductive arylation of activated alkynes with aryl iodides. Tetrahedron Lett 2015;56:3365-7. [PMID: 26028781 DOI: 10.1016/j.tetlet.2015.02.120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Zuo S, Li S, Yu R, Zheng G, Cao Y, Zhang S. Discovery of novel 3-benzylquinazolin-4(3 H )-ones as potent vasodilative agents. Bioorganic & Medicinal Chemistry Letters 2014;24:5597-601. [DOI: 10.1016/j.bmcl.2014.10.092] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Abdel-atty MM, Farag NA, Kassab SE, Serya RA, Abouzid KA. Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents. Bioorganic Chemistry 2014;57:65-82. [DOI: 10.1016/j.bioorg.2014.08.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
9 Asif M. Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives. Int J Med Chem 2014;2014:395637. [PMID: 25692041 DOI: 10.1155/2014/395637] [Cited by in Crossref: 35] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
10 Wu M, Li Y, Fu X, Wang J, Zhang S, Yang L. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method. Int J Mol Sci 2014;15:15475-502. [PMID: 25257526 DOI: 10.3390/ijms150915475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 Waiker DK, Karthikeyan C, Poongavanam V, Kongsted J, Lozach O, Meijer L, Trivedi P. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors. Bioorganic & Medicinal Chemistry 2014;22:1909-15. [DOI: 10.1016/j.bmc.2014.01.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Macneil DJ. The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front Endocrinol (Lausanne) 2013;4:49. [PMID: 23626585 DOI: 10.3389/fendo.2013.00049] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
13 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]